Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0 mg over 6 cycles in female adolescents, with a 7-cycle extension phase
To assess the safety, tolerability and bleeding patterns of drospirenone 4.0 mg.
Source: Contraception - Category: OBGYN Authors: Dan Apter, Enrico Colli, Kristina Gemzell-Danielsson, Klaus Peters Tags: Original Research Article Source Type: research